The Journal of Immunology, Vol 158, Issue 7 3181-3188, Copyright © 1997 by American Association of Immunologists

ARTICLES

Degenerate MHC restriction reveals the contribution of class I MHC molecules in determining the fine specificity of CTL recognition of an immunodominant determinant of HIV-1 gp160 V3 loop

M Shirai, S Kozlowski, DH Margulies and JA Berzofsky
Metabolism Branch, National Cancer Institute, Bethesda, MD 20892, USA.

The novel allogeneic presentation of an immunodominant determinant within the HIV-1 gp160 V3 loop by three different class I MHC molecules to the same CD8+ CTL is used to study the influence of the MHC molecule on the fine specificity of CTL recognition. We previously reported that four distinct class I molecules of H-2d,u,p,q presented the V3 decapeptide P18-I10 (RGPGRAFVTI) to CTL. Surprisingly, we found that H- 2d,u,p cells mutually cross-present the P18-I10 peptide to allogeneic CTL clones of each of the other haplotypes, whereas none of these cross- presents to H-2q CTL, nor do H-2q targets present to CTL of the other haplotypes. Here, we explore the critical amino acid residues for the cross-presentation using 10 variant peptides with single amino acid substitutions. The fine specificity examined using these mutant peptides presented by the same MHC class I molecule showed striking similarity among the CTL of each haplotype, expressing either V beta 8.1 or V beta 14. In contrast, the fine specificity is different between the distinct MHC class I molecules even for the lysis by the same CTL, as shown by reciprocal effects of the same substitutions. Thus, peptide fine specificity of a single TCR is influenced by changes in the class I MHC molecules presenting the Ag.

This article has been cited by other articles:

				N. F. Rose, J. Publicover, A. Chattopadhyay, and J. K. Rose Hybrid alphavirus-rhabdovirus propagating replicon particles are versatile and potent vaccine vectors PNAS, April 15, 2008; 105(15): 5839 - 5843. [Abstract] [Full Text] [PDF]

				K.-Q. Xin, Y. Hoshino, Y. Toda, S. Igimi, Y. Kojima, N. Jounai, K. Ohba, A. Kushiro, M. Kiwaki, K. Hamajima, et al. Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env Blood, July 1, 2003; 102(1): 223 - 228. [Abstract] [Full Text] [PDF]

				K. Haglund, I. Leiner, K. Kerksiek, L. Buonocore, E. Pamer, and J. K. Rose Robust Recall and Long-Term Memory T-Cell Responses Induced by Prime-Boost Regimens with Heterologous Live Viral Vectors Expressing Human Immunodeficiency Virus Type 1 Gag and Env Proteins J. Virol., June 27, 2002; 76(15): 7506 - 7517. [Abstract] [Full Text] [PDF]

				P. K. Hocknell, R. D. Wiley, X. Wang, T. G. Evans, W. J. Bowers, T. Hanke, H. J. Federoff, and S. Dewhurst Expression of Human Immunodeficiency Virus Type 1 gp120 from Herpes Simplex Virus Type 1-Derived Amplicons Results in Potent, Specific, and Durable Cellular and Humoral Immune Responses J. Virol., May 3, 2002; 76(11): 5565 - 5580. [Abstract] [Full Text] [PDF]

				K. Haglund, I. Leiner, K. Kerksiek, L. Buonocore, E. Pamer, and J. K. Rose High-Level Primary CD8+ T-Cell Response to Human Immunodeficiency Virus Type 1 Gag and Env Generated by Vaccination with Recombinant Vesicular Stomatitis Viruses J. Virol., February 22, 2002; 76(6): 2730 - 2738. [Abstract] [Full Text] [PDF]

				W. Zhang, S. M. Lonning, and T. C. McGuire Gag Protein Epitopes Recognized by ELA-A-Restricted Cytotoxic T Lymphocytes from Horses with Long-Term Equine Infectious Anemia Virus Infection J. Virol., December 1, 1998; 72(12): 9612 - 9620. [Abstract] [Full Text] [PDF]